Breast cancer markers

被引:36
作者
Giancotti, Vincenzo [1 ]
机构
[1] Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy
关键词
breast cancer; markers; kinases;
D O I
10.1016/j.canlet.2006.01.035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review illustrates the relationships linking the ER and the ErbB family of receptor tyrosine kinases and their kinase pathways in breast cancer. The central role of the ER in activating tumour growth linked gene transcription as well as the cooperating nuclear co-factors very likely implicated in breast cancer tumourigenesis is discussed. The action of ErbB family members has been located upstream of the kinase pathways that begin at plasma membrane and end at the nucleus after complex interconnections with many factors, such as AP-1. The important role of MAPKs and PKB/Akt in cell survival and tumour proliferation is highlighted. Also other factors are discussed such as Fra-1 (a member of the AP-1 complex), E-cadherin (a tumour suppressor), and BRCA1 (another factor involved in tumour growth inhibition). Lactoferrin protein (characteristic of healthy tissues) and resistance proteins have also been briefly discussed. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:145 / 159
页数:15
相关论文
共 104 条
[41]  
Hwang ES, 2004, BREAST CANCER RES TR, V88, pS11
[42]   A review of adjuvant hormonal therapy in breast cancer [J].
Jones, KL ;
Buzdar, AU .
ENDOCRINE-RELATED CANCER, 2004, 11 (03) :391-406
[43]   Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2 [J].
Kage, K ;
Fujita, T ;
Sugimoto, Y .
CANCER SCIENCE, 2005, 96 (12) :866-872
[44]   Estrogen receptor α rapidly activates the IGF-1 receptor pathway [J].
Kahlert, S ;
Nuedling, S ;
van Eickels, M ;
Vetter, H ;
Meyer, R ;
Grohé, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18447-18453
[45]   Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells [J].
Kim, DW ;
Sovak, MA ;
Zanieski, G ;
Nonet, G ;
Romieu-Mourez, R ;
Lau, AW ;
Hafer, LJ ;
Yaswen, P ;
Stampfer, M ;
Rogers, AE ;
Russo, J ;
Sonenshein, GE .
CARCINOGENESIS, 2000, 21 (05) :871-879
[46]   Forkhead transcription factors are targets of signalling by the proto-oncogene PKB (C-AKT) [J].
Kops, GJPL ;
Burgering, BMT .
JOURNAL OF ANATOMY, 2000, 197 :571-574
[47]   Relevance of breast cancer cell lines as models for breast tumours: an update [J].
Lacroix, M ;
Leclercq, G .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 83 (03) :249-289
[48]   Protein kinase CK2 in mammary gland tumorigenesis [J].
Landesman-Bollag, E ;
Romieu-Mourez, R ;
Song, DH ;
Sonenshein, GE ;
Cardiff, RD ;
Seldin, DC .
ONCOGENE, 2001, 20 (25) :3247-3257
[49]   HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways [J].
Le, XF ;
Pruefer, F ;
Bast, RC .
CELL CYCLE, 2005, 4 (01) :87-95
[50]   Elevated phosphorylation and activation of PDK-I/AKT pathway in human breast cancer [J].
Lin, HJ ;
Hsieh, FC ;
Song, H ;
Lin, J .
BRITISH JOURNAL OF CANCER, 2005, 93 (12) :1372-1381